Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Charvat, US

George F. Charvat, East Troy, WI US

Patent application numberDescriptionPublished
20090255381Coupling mechanisms for detachably engaging tool attachments - Coupling mechanisms for engaging and releasing a tool attachment such as a socket from a drive element include an engaging element and an actuating element. The actuating element can include a collar or other manually-accessible part, and various features allow for a relatively small outside diameter for the collar or other part. These features include configuring the actuating element to contact the engaging element within the drive element, placing the biasing elements within the drive element, and forming guides for parts of the actuating element within the drive element Also, the engaging element can move along a direction that is oriented at an oblique angle to the longitudinal axis of the drive element, in whole or in part. The engaging element can have a first part that moves obliquely in the drive element and a second part that moves radially in the drive element to engage the tool attachment.10-15-2009

George F. Charvat, Lombard, IL US

Patent application numberDescriptionPublished
20090049958TOOLS FOR DETACHABLY ENGAGING TOOL ATTACHMENTS - Tools for detachably engaging a tool attachment are described that include a drive element and a mechanism for altering engagement forces between the tool attachment and the drive element. The mechanism includes a locking element and an actuating element coupled to the locking element.02-26-2009

Patent applications by George F. Charvat, Lombard, IL US

Jana T. Charvat, East Troy, WI US

Patent application numberDescriptionPublished
20110296962Coupling Mechanisms for Detachable Engaging Tool Attachments - Coupling mechanisms for engaging and releasing a tool attachment such as a socket from a drive element include an engaging element and an actuating element. The actuating element can include a collar or other manually-accessible part, and various features allow for a relatively small outside diameter for the collar or other part. These features include configuring the actuating element to contact the engaging element within the drive element, placing the biasing elements within the drive element, and forming guides for parts of the actuating element within the drive element. Also, the engaging element can move along a direction that is oriented at an oblique angle to the longitudinal axis of the drive element, in whole or in part. The engaging element can have a first part that moves obliquely in the drive element and a second part that moves radially in the drive element to engage the tool attachment.12-08-2011

Leo D. Charvat, Lincoln, NE US

Patent application numberDescriptionPublished
20080227637A Method of Controlling Weeds - The present invention relates to the use of 3-phenyluracils of formula (I) wherein the variables R09-18-2008
20110162268Method for Increasing the Number of Seedlings Per Number of Sowed Grains of Seed - The present invention relates to a method for increasing the number of seedlings per number of sowed grains of seed comprising a) treating seed with a pesticide and an aqueous compositions comprising a polymer selected from vinylidene chloride copolymer or chitosan; and b) drying said treated seed. The present invention further relates to the use of a polymer selected from vinylidene chloride copolymer or chitosan for increasing the number of seedlings per number of sowed grains of seed, wherein the seed has been treated with a pesticide.07-07-2011

Trevor T. Charvat, San Jose, CA US

Patent application numberDescriptionPublished
20090005410N-(2-(HETARYL)ARYL) ARYLSULFONAMIDES AND N-(2-(HETARYL) HETARYL ARYLSULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.01-01-2009
20100056509HETEROARYL SULFONAMIDES AND CCR2 - Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists.03-04-2010
20100152186TRIAZOLYL PYRIDYL BENZENESULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists and as controls in assays for the identification of CCR9 antagonists.06-17-2010
20100190762TRIAZOLYL PHENYL BENZENESULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists and as controls in assays for the identification of CCR9 antagonists.07-29-2010
20100331302N-(2-(HETARYL)ARYL) ARYLSULFONAMIDES AND N-(2-(HETARYL)HETARYL ARYLSULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.12-30-2010
20110082172PYRROLIDINONE CARBOXAMIDE DERIVATIVES - Pyrrolidinone carboxamide compounds are provided that are useful for inhibiting the binding of ligands to the ChemR23 receptor.04-07-2011
20110118248Heteroaryl sulfonamides and CCR2/CCR9 - Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists.05-19-2011

Patent applications by Trevor T. Charvat, San Jose, CA US